Bioaerosol Science

Inline Bioaerosol Reduction

Measure single-pass bioaerosol reduction across in-duct and inline devices using defined microbial loads, flow conditions, and sampling intervals.

We compare upstream and downstream microbial aerosol concentrations using device-off controls, logged airflow, and culture, qPCR, or ddPCR endpoints.

ISO 17025ASHRAE 241ASHRAE 62.1ISO 16000-36Reviewed 2026-05-16
Request a quoteSubmit a sample

Purpose & when to use

Inline bioaerosol reduction testing quantifies the change in microbial aerosol concentration across an in-duct, enclosed-flow, or device-mounted treatment system during a single pass. ARE Labs controls the duct section, challenge generation, airflow, and sampling schedule, then collects paired upstream and downstream samples using viable samplers or filter trains. Culture, qPCR, or droplet digital PCR (ddPCR) endpoints quantify the collected material for ISO 17025 study records and ASHRAE 241-aligned reduction metrics.

  1. In-duct HVAC air-cleaner comparison under ASHRAE 241 context, using defined flow, upstream/downstream samplers, and device-off baselines for single-pass reduction.
  2. UVGI or active-treatment module verification for building ventilation systems, using ASHRAE 62.1 airflow context, UV or mode logs, and viable recovery.
  3. Inline medical or scavenging interface screening under ISO 17025 controls, using sealed adapters, bioaerosol load control, and qPCR or ddPCR endpoint quantitation.
  4. ISO 16000 indoor-air duct studies for air-treatment products, using defined injection, downstream sampling, RH and temperature logging, and replicate condition blocks.
  5. EPA antimicrobial product performance support for air-treatment claims, using organism selection, device-off controls, recovery checks, and reduction metrics matched to claim language.

Use inline bioaerosol reduction testing when the decision depends on the microbial aerosol reduction measured during one pass through a defined flow path. Before testing begins, the protocol fixes the airflow, microbial load, sampling intervals, analytical endpoint, and standard or claim framework.

Built for inline and ducted air-treatment devices

Inline bioaerosol reduction studies serve products where airflow path, mounting geometry, and device mode determine the microbial reduction result under ASHRAE, ISO, or EPA claim frames.

  • Duct unitsInstalled HVAC treatment modules
  • UVGI modulesInline ultraviolet treatment
  • Air cleanersDucted and hybrid systems
  • Scavenging interfacesEnclosed clinical flow paths
  • Control systemsMode and fan logic

Instrumentation & measurement ranges

We select the test platform based on the flow path, organism or surrogate, required endpoint sensitivity, and device operating mode.

10 - 1000 L/minchallenge-flow

Inline duct sections and adapters

Duct sections, sealed adapters, and mounting fixtures define upstream injection, downstream sampling, bypass control, and device-under-test placement.

0.1 - 10 mL/minliquid-feed

Bioaerosol generators and load control

Nebulizers or protocol-specific generators introduce organism or surrogate loads at defined release rates with pre-run background checks.

1 - 30 L/minsampler-flow

Viable samplers and molecular collection

Impingers, filter holders, and timed collection trains capture upstream and downstream bioaerosol samples for interval-by-interval reduction calculations.

10 - 10000000 copiesquantitation

Culture, qPCR, and ddPCR endpoints

Culture and molecular assays convert collected material into viable counts, gene copies, or absolute copy number depending on organism and study objective.

20 - 80 RHcondition-control

Flow and environmental logging

Flow, RH, temperature, device speed, duty cycle, and UV or active-treatment settings are logged through every baseline and device-on run.

Test method options

MethodStrengthsTradeoffAligned with
ASHRAE 241 aligned inline reduction study
  • Connects upstream/downstream bioaerosol recovery to infectious aerosol control and equivalent clean airflow concepts for in-duct air-treatment devices.
  • Device-off baselines and interval sampling distinguish treatment effect from line loss, natural decay, and sampler recovery behavior.
Flow uniformity, challenge stability, and repeated baseline runs must be controlled before single-pass reduction values are comparable.
ASHRAE 241ISO 17025
Ventilation-system inline mapping study
  • Uses ASHRAE 62.1 airflow context and ISO 16000-36 aligned sampling logic to compare duct devices, UVGI modules, and hybrid systems.
  • Multi-speed and duty-cycle mapping identifies best-case, worst-case, and normal operating points using the same upstream/downstream geometry.
Each fan speed, mode, or duty cycle adds replicate blocks, increasing run count and data-review time.
ASHRAE 62.1ISO 16000-36
EPA claim-support inline screening
  • Frames organism selection, controls, and reduction outputs for EPA antimicrobial product performance discussions when air-treatment claim language requires support.
  • Fit-for-purpose endpoint selection allows culture, qPCR, or ddPCR reporting based on viability needs, biosafety limits, and product mechanism.
Claim fit depends on organism, exposure time, device geometry, and whether single-pass reduction is the right evidence for the label.
EPA antimicrobial product performanceISO 17025

Setup configurations

Every inline study begins with the device geometry, airflow setpoint, challenge organism or surrogate, and intended claim frame. From there, we define how to establish the upstream load, measure downstream recovery, check for bypass, track environmental drift, and document each device operating mode. These setup conditions are fixed in the protocol before the first reduction run:

Device interfaces

Duct insertion, sealed adapter, tube section, or clinical interface mounting documented with photographs, seals, bypass checks, and sampling-port locations.

Flow & actuation profiles

Volumetric flow, fan speed, duty cycle, treatment mode, UV setting, and stabilization period defined for each condition.

Exposure profile

Upstream injection location, challenge load, sampling interval, device-on timing, and run duration matched to expected reduction.

Sample numbers

Replicate device-on runs, device-off baselines, blanks, and background checks sized to variability and the decision threshold.

Calibration & verification

Sampler flow, duct flow, environmental sensors, generator output, endpoint controls, and recovery checks verified within the study record.

Methods anchored to the standards that matter

Inline studies distinguish the accredited laboratory quality system from the building, indoor-air, and method frameworks applied to the test. Together, these anchors define the study records, airflow controls, and reporting language for the selected design.

  • ISO 17025AccreditedTesting-laboratory competence, traceable calibration, method records, and data review.
  • ASHRAE 241AlignedInfectious aerosol control and equivalent clean airflow context.
  • ASHRAE 62.1AlignedVentilation-system airflow and indoor air quality context.
  • ISO 16000-36AlignedIndoor-air chamber and microorganism reduction context.

Key data outputs & reporting

Inline bioaerosol reduction reports pair device operating records with upstream and downstream microbial concentrations for every sampling interval and test condition. Reported results include single-pass reduction, device-off baselines, comparisons across modes or speeds, replicate statistics, endpoint recovery, airflow and environmental logs, and supporting QA / QC records. The interpretation explains how the data may support product, building, or antimicrobial claim decisions under the tested conditions.

Primary outputs

  • Upstream and downstream concentration by sampling interval, endpoint, device mode, and replicate.
  • Single-pass percent reduction and optional CADR-like bioaerosol equivalent, with calculation basis stated as fit for purpose.
  • Device-off baseline and blank results used to separate treatment effect from duct loss, background, and sampler artifacts.
  • Flow, RH, temperature, UV or treatment settings, fan speed, and duty-cycle records tied to each run.

Deliverables

#FormatContents
01PDF reportMethods, configuration, controls, reduction results, QA / QC, and study interpretation.
02CSV / XLSX datasetsInterval concentrations, reductions, recovery checks, replicates, and environmental records.
03FiguresUpstream/downstream comparisons, mode overlays, and reduction summaries by condition.

QA / QC & data integrity

Inline bioaerosol studies use controls to separate device-related reduction from duct loss, background contamination, sampler recovery, assay variability, and environmental drift. ARE Labs maintains ISO 17025 quality-system records from organism receipt or preparation through final data review. Instrument calibration, sample handling, analytical endpoints, calculations, and quality checks remain traceable throughout the study.

Device-off controls and background runs define baseline line loss and pre-challenge conditions.

Sampler blanks, media blanks, extraction controls, and assay controls track contamination and endpoint background.

Recovery checks for impingers, filters, extraction steps, and culture or molecular assays support quantitation limits.

Replicate runs and repeated sequences quantify variability across device speeds, modes, organisms, or flow setpoints.

Calibration records cover sampler flow, duct flow, RH, temperature, and UV or treatment instrumentation when used.

Chain of custody tracks organisms, devices, collected samples, extracts, and raw instrument files.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
17025Accredited testing
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

These answers cover the questions HVAC engineers, air-treatment developers, UVGI teams, medical-device teams, and antimicrobial product groups commonly raise when planning inline bioaerosol reduction studies. Topics include single-pass calculations, device-off baselines, organism and surrogate selection, multi-speed mapping, CADR-like bioaerosol equivalents, and study deliverables. If your flow path, device geometry, or intended claim falls outside these examples, contact us to discuss an appropriate study design.

Q.How is inline reduction different from room efficacy?
A.Inline testing measures the reduction achieved during one pass through a defined flow path. Room efficacy testing instead measures concentration decay over time within a mixed volume. The appropriate setup depends on whether the device operates in a duct, tube, interface, or open room.
Q.Do you provide CADR-like bioaerosol metrics?
A.Yes, when the calculation is fit for purpose. The report identifies the airflow basis, concentration inputs, controls, and assumptions so a CADR-like bioaerosol value is not mistaken for a result generated using a fixed AHAM method.
Q.Can you test multiple fan speeds or duty cycles?
A.Yes. Multi-speed and duty-cycle mapping is common for ducted devices. We run replicate blocks at each condition and include device-off controls so operating modes can be compared using the same baseline and calculation method.
Q.Which endpoints can be used?
A.Culture, qPCR, and ddPCR endpoints are available. Selection depends on the organism, the viability question, biosafety limits, and the expected reduction range. The protocol defines recovery checks and quantitation limits before testing begins.
Q.What do I receive after testing?
A.You receive a PDF report, CSV or XLSX datasets, and figures showing upstream and downstream concentrations, single-pass reduction, control results, recovery checks, airflow records, environmental conditions, and interpretation within the study limits.

Standards & guidance

We scope each inline bioaerosol reduction study to the standard or guidance that fits the device, airflow path, organism, endpoint, and intended claim. ISO 17025 remains the accredited quality-system anchor. ASHRAE 241, ASHRAE 62.1, ISO 16000-36, and EPA antimicrobial product performance guidance are used as alignment frameworks when they fit the study design and reporting objective.

QA & Regulatory - Accredited

ISO 17025

Testing-laboratory competence, documented methods, calibration traceability, uncertainty, and data reviewView standard ->Bioaerosol & Indoor Air - Aligned

ASHRAE 241

Control of infectious aerosols and equivalent clean airflow context for inline air-treatment studiesView standard ->Building Ventilation - Aligned

ASHRAE 62.1

Ventilation-system airflow and indoor air quality context for ducted device evaluationsView standard ->Bioaerosol & Indoor Air - Aligned

ISO 16000-36

Indoor-air test context for airborne microorganism reduction studiesView standard ->EPA & Claims - Aligned

EPA antimicrobial product performance

EPA antimicrobial product performance context for organism selection, controls, and claim-support framingView standard ->

Related services & devices

Service

Bioaerosol Efficacy Testing (Room)

Use when the reduction question is room-scale decay rather than single-pass removal through a flow path.Read more ->Devices

Air Treatment

Portable, in-duct, UVGI, and hybrid devices that need microbial reduction data under defined airflow.Read more ->Service

Device Challenge Aerosol

Pairs with inline reduction when device response, detection, or collection behavior must be checked against a measured challenge.Read more ->Devices

Medical Devices

Clinical and patient-facing devices where enclosed-flow microbial reduction data support design decisions.Read more ->